Cargando…

Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study

Detalles Bibliográficos
Autores principales: Zhou, Suizi, Liu, Yibin, Xue, Jianrong, Tang, Jun, Yu, Qingqing, Qu, Shenhong, Zhang, Shaojie, Mo, Binyu, Li, Jihui, Liu, Yinhong, Yang, Yueying, Wang, De‐Yun, Qiu, Qianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886642/
https://www.ncbi.nlm.nih.gov/pubmed/35251592
http://dx.doi.org/10.1002/clt2.12122
_version_ 1784660710657097728
author Zhou, Suizi
Liu, Yibin
Xue, Jianrong
Tang, Jun
Yu, Qingqing
Qu, Shenhong
Zhang, Shaojie
Mo, Binyu
Li, Jihui
Liu, Yinhong
Yang, Yueying
Wang, De‐Yun
Qiu, Qianhui
author_facet Zhou, Suizi
Liu, Yibin
Xue, Jianrong
Tang, Jun
Yu, Qingqing
Qu, Shenhong
Zhang, Shaojie
Mo, Binyu
Li, Jihui
Liu, Yinhong
Yang, Yueying
Wang, De‐Yun
Qiu, Qianhui
author_sort Zhou, Suizi
collection PubMed
description
format Online
Article
Text
id pubmed-8886642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88866422022-03-04 Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study Zhou, Suizi Liu, Yibin Xue, Jianrong Tang, Jun Yu, Qingqing Qu, Shenhong Zhang, Shaojie Mo, Binyu Li, Jihui Liu, Yinhong Yang, Yueying Wang, De‐Yun Qiu, Qianhui Clin Transl Allergy Letter John Wiley and Sons Inc. 2022-03-01 /pmc/articles/PMC8886642/ /pubmed/35251592 http://dx.doi.org/10.1002/clt2.12122 Text en © 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Zhou, Suizi
Liu, Yibin
Xue, Jianrong
Tang, Jun
Yu, Qingqing
Qu, Shenhong
Zhang, Shaojie
Mo, Binyu
Li, Jihui
Liu, Yinhong
Yang, Yueying
Wang, De‐Yun
Qiu, Qianhui
Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title_full Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title_fullStr Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title_full_unstemmed Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title_short Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
title_sort sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the covid‐19 pandemic: a multicenter, two‐arm, real‐world study
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886642/
https://www.ncbi.nlm.nih.gov/pubmed/35251592
http://dx.doi.org/10.1002/clt2.12122
work_keys_str_mv AT zhousuizi sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT liuyibin sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT xuejianrong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT tangjun sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT yuqingqing sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT qushenhong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT zhangshaojie sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT mobinyu sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT lijihui sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT liuyinhong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT yangyueying sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT wangdeyun sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy
AT qiuqianhui sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy